Know Your Rights as an Immigrant
January 22, 2025We outline key rights every immigrant should know to help protect themselves and their families.
Boundless Blog
Trump’s Day 1 Immigration Executive Orders Explained
January 21, 2025On his first day back in office, President Donald Trump issued a series of sweeping executive orders related to immigration.
The Impact of Corporate Restructuring on Immigration Applications
January 16, 2025Corporate restructuring — whether a merger, acquisition, spin-off, or reorganization — can have far-reaching consequences
Trump’s Staff and Their Role in Shaping Immigration Policies
January 13, 2025The return of Donald Trump to the U.S. presidency could have far-reaching consequences for employment-based immigration policies.
Cap Reached for Additional H-2B Visas for First Half of FY 2025
January 13, 2025The government is still accepting applications for the 20,000 H-2B visas reserved for nationals of certain countries and for workers exempt from the cap.
Visa Bulletin Archive for February 2025
January 11, 2025The U.S. Department of State released its latest Visa Bulletin. That’s a big deal if you’re waiting for your priority date to be current so that your green card application can move forward.
Permanent Resident vs. Citizen: What’s the Difference?
January 10, 2025Learn the differences between lawful permanent residency and citizenship.
DHS Launches Sweeping AI Immigration Plan: A Major Shift for 2025 and Beyond
January 8, 2025As the Department of Homeland Security rolls out its most ambitious artificial intelligence initiative yet, every aspect of the U.S. immigration system stands on the brink of transformation. This landmark shift in how applications are processed arrives at a pivotal… View Article
U.S. to Refund $55 Million in Fees for Blocked Parole in Place Expansion
January 8, 2025USCIS will refund $55M in fees for blocked immigration program aimed at helping undocumented spouses of U.S. citizens.
USCIS Scraps Naturalization Test Redesign
December 30, 2024The federal agency said it was ending the trial, announced in 2022, due to negative feedback about changes to the test.